Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
69663-60-1
|
| gptkbp:chirality |
S
|
| gptkbp:has_teratogenic_effect |
true
|
| gptkbp:hasEnantiomer |
gptkb:thalidomide
|
| gptkbp:hasMolecularFormula |
C13H10N2O4
|
| gptkbp:hasSMILES |
O=C1NC(=O)C2=CC=CC=C2C1C3=CC=CC=C3N4C(=O)CCC4=O
|
| https://www.w3.org/2000/01/rdf-schema#label |
(S)-thalidomide
|
| gptkbp:isomerOf |
gptkb:(R)-thalidomide
|
| gptkbp:IUPACName |
(S)-2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione
|
| gptkbp:part_of |
thalidomide racemate
|
| gptkbp:bfsParent |
gptkb:thalidomide
|
| gptkbp:bfsLayer |
7
|